Showing results (1041-1050 of 1,128) with videos related to
Sort By:
Pageof 113
Annals of Surgical Oncology|June 15, 2024
Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancreatic CancerPhoebe N Miller, Fernanda Romero-Hernandez, Lucia Calthorpe, et al.Cancer Discovery|June 26, 2015
Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary CarcinomasOliver A Zill, Claire Greene, Dragan Sebisanovic, et al.Biochemical and Biophysical Research Communications|July 23, 2025
Induced lung epithelial-like cells derived by direct reprogramming rescue influenza virus-induced lung injury in miceTatsuya Kusumoto, Masaya Yotsukura, Takanori Asakura, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2016
Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice GuidelineEdward P Balaban, Pamela B Mangu, Alok A Khorana, et al.Proceedings of the National Academy of Sciences of the United States of America|October 5, 2017
<i>Period2</i> 3'-UTR and microRNA-24 regulate circadian rhythms by repressing PERIOD2 protein accumulationSeung-Hee Yoo, Shihoko Kojima, Kazuhiro Shimomura, et al.Nature|June 22, 2010
Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetesBiliana Marcheva, Kathryn Moynihan Ramsey, Ethan D Buhr, et al.Journal of Nanoscience and Nanotechnology|September 17, 2015
Comparison of Strain in GaN-Based Blue Light-Emitting Diode Grown on Silicon(111) and Sapphire SubstratesK S Jeon, J H Sung, M W Lee, et al.British Journal of Cancer|November 13, 2003
BRAF mutations in non-Hodgkin's lymphomaJ W Lee, N J Yoo, Y H Soung, et al.Cancer Research Communications|February 5, 2025
A Phase 2 Study of Sotigalimab, a CD40 Agonist Antibody, plus Concurrent Chemoradiation as Neoadjuvant Therapy for Esophageal and Gastroesophageal Junction CancersAndrew H Ko, Joseph Chao, Marcus S Noel, et al.Blood Advances|August 8, 2022
Surgical outcomes in people with hemophilia A taking emicizumab prophylaxis: experience from the HAVEN 1-4 studiesRebecca Kruse-Jarres, Flora Peyvandi, Johannes Oldenburg, et al.Pageof 113